Abstract：【Objective】To investigate the effect of low molecular weight heparin (LMWH) on the proliferation and the SDF-1expression of primary cultured gastric carcinoma cells. 【Methods】Poorly differentiated adenocarcinoma of the stomach tissues and normal gastric mucosa tissues were made into primary cells and then divided into four groups:group A had gastric cancer cells, group B had gastric cancer cells + LMWH, group C had gastric mucosal cells, and group D had gastric mucosal cells + LMWH. The cell proliferation was detected by MTT assay, the cell cycle distribution and apoptosis was detected by V-FITC/PI assay, and the expression of SDF-1 mRNA was examined by semi-quantitative RT-PCR.【 Results】 The proliferation of gastric carcinoma cells in group B was much lower than in group A. At the same time, cell apoptosis was higher in group B than in group A. In the G0 and Gl phases,there was a higher ratio of cells but a lower ratio was observed in the S period. There was no significant difference in cell ratios in the G2 and M phases between these two groups.For groups C and D, there was no significant difference for cell proliferation, cell cycle, or apoptosis. The expression of SDF-1 mRNA was lower in group B than in group A. There was no significant difference in the expression of SDF-1 mRNA in groups C and D. 【Conclusion】LMWH can inhibit the proliferation of primary gastric carcinoma cells and also increase the cell apoptosis, changing the structure of the cell cycle and reducing the expression of SDF-1 mRNA in primary cells of gastric cancer.
潘畅;王书青;邱明科;漆先琴;欧敬民;沈军. 低分子肝素对胃癌原代细胞增殖及SDF-1表达的影响[J]. 医学临床研究, 2016, 33(10): 1976-1979.
PAN Chang, WANG Shu-qing, QIU Ming-ke, et al. Effects of Low Molecular Weight Heparin on the Proliferation and SDF-1 Expression of Primary Gastric Cancer Cells. JOURNAL OF CLINICAL RESEARCH, 2016, 33(10): 1976-1979.
[1] 冯新,曹一鑫,王建力,等.低分子肝素对细胞株生物学行为的干预研究[J].中华皮肤科杂志,2012, 45(8):577-581. [2] 王启船.低分子肝素联合化疗治疗晚期乳腺癌的疗效及对血栓标志物的影响[J].中国老年学杂志,2013, 33(18):4567-4568. [3] 刘飞,李汉军,李介秋,等.低分子肝素对种植性乳腺癌生长和转移的抑制作用[J].中华实验外科杂志, 2010, 27(1):50-52. [4] Che DH, Cao JY, Shang LH,et al.The efficacy and safety of low-molecular-weight heparin use for cancer treatment: A meta-analysis[J].Eur J Intern Med,2013, 24(5):433-439. [5] 狄岩,张增叶.肝素抗肿榴机制研究进展[J].临床荟萃, 2000,15(8):381-382. [6] 李红良,陈丹丹,罗英儒.肝素增强佛波酯对人鼻咽癌CNE2细胞的作用[J].中国病理生理杂志,2002,18(3):250-255. [7] 李红良,陈丹丹,罗英儒.肝素对义孢素介导的人鼻咽癌CNE2细胞的增殖与凋亡的影响[J].中国病理生理杂志,2002,18(2):337-343. [8] Taromi S, Catusse J, Elverfeldt DV,et al.PO-33 -Heparin suppresses progression of small cell lung cancer(SCLC) in an orthotopic mouse model[J].Thromb Res,2016,140(Suppl 1):S188. [9] Sudha T, Yalcin M, Lin HY,et al. Suppression of pancreatic cancer by sulfated non-anticoagulant low molecular weight heparin[J].Cancer Lett,2014 ,350(1-2):25-33. [10] 宋明旭,李莉华,刘志辉,等.低分子肝素对胃癌细胞增殖及其表达的影响[J].山东医药, 2008, 48(33):25-26. [11] Xu L, Li Y, Sun H, et al.Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches. Molecular bioSystems[J].Mol Biosyst,2013,9(8):2007-2017.
2016, Vol. 33 
